TSS
CRBP icon

Two Sigma Securities’s Corbus Pharmaceuticals CRBP Stock Holding History

Two Sigma Securities’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,817
Closed -$9.34K – 2756
2022
Q4 		$9.34K Buy
+2,817
New +$10.8K ﹤0.01% 2373
2022
Q3 		– Sell
-1,276
Closed -$10K – 2673
2022
Q2 		$10K Buy
+1,276
New +$12.3K ﹤0.01% 2051
2022
Q1 		– Sell
-1,533
Closed -$28K – 2165
2021
Q4 		$28K Buy
+1,533
New +$41.5K ﹤0.01% 1369
2021
Q3 		– Sell
-778
Closed -$43K – 1614
2021
Q2 		$43K Buy
+778
New +$43.2K ﹤0.01% 1407
2018
Q1 		– Sell
-376
Closed -$80K – 2696
2017
Q4 		$80K Buy
+376
New +$80.5K ﹤0.01% 1477

Other funds holding CRBP

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Two Sigma Securities's CRBP Position: Q1 2023 in Review

Two Sigma Securities sold out of Corbus Pharmaceuticals (CRBP) in Q1 2023, closing a stake of 2,817 shares — an estimated $9.34K sold.

Two Sigma Securities first reported a position in CRBP in Q4 2017 and held it in 5 quarters. The position peaked at $80K in Q4 2017. 30 funds tracked by Wall St. Rank hold CRBP as of Q1 2023.

  • Two Sigma Securities reported no remaining Corbus Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Two Sigma Securities sold 2,817 Corbus Pharmaceuticals shares in Q1 2023, an estimated $9.34K.
  • Two Sigma Securities first reported a position in Corbus Pharmaceuticals in Q4 2017 and held it in 5 quarters.
  • Two Sigma Securities's Corbus Pharmaceuticals position peaked at $80K in Q4 2017.
  • 30 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2023.

Based on Two Sigma Securities's 13F filing for Q1 2023, filed 15 May 2023.